| Date Filed | Type | Description |
| 05/05/2023 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 4,601 options to buy
@ $130.14, valued at
$598.8k
Granted 732 restricted stock units
@ $0 |
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Exercised 703 restricted stock units
@ $0
Granted 4,061 options to buy
@ $142.52, valued at
$578.8k
Granted 670 restricted stock units
@ $0 |
|
| 08/20/2021 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Gifted 2,700 shares
@ $0 |
|
| 06/21/2021 |
4
| Berenson Stephen (Director) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 23,000 options to buy
@ $19.74, valued at
$454k
|
|
| 04/30/2021 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 4,081 options to buy
@ $178.68, valued at
$729.2k
Granted 703 restricted stock units
@ $0 |
|
| 11/25/2020 |
4
| Berenson Stephen (Director) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Acquired 3,589 shares
@ $0 |
|
| 06/22/2020 |
4
| Berenson Stephen (Director) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.4, valued at
$132k
|
|
| 04/30/2020 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 18,270 options to buy
@ $46.37, valued at
$847.2k
|
|
| 08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2018 |
4
| Berenson Stephen (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Converted 22,798 shares
@ $0
Converted 22,798 preferred shares
@ $0 |
|
| 12/07/2018 |
3
| Berenson Stephen (Director) has filed a Form 3 on Moderna, Inc. |